RNA biology
Cure8 research brief
Crosstalk between circRNAs and the classic signaling pathways in IBD.
Research and clinical trials
Biomarkers
Microbiome
Drug Discovery
Biomarker
Clinical study
Researchers
Clinicians
Why This Matters
Researchers are exploring circRNAs as new molecular players in IBD inflammation; that could lead to future biomarker tests or novel treatments targeting immune pathways relevant to Crohn’s disease and ulcerative colitis.
For patients, this is early-stage research that may influence diagnostics or therapies down the line but does not change current care now.
Who Should Pay Attention
Researchers studying IBD molecular mechanisms, clinicians interested in biomarkers and translational research, and patients following emerging diagnostic or therapeutic research.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The paper is a review, not a clinical trial. It synthesizes lab and early translational research linking circRNAs to immune signaling pathways implicated in IBD pathogenesis, and discusses challenges for moving circRNA findings toward clinical use. It does not provide clinical recommendations or validated diagnostic tests.
If you follow IBD research: this points to emerging molecular biomarkers and possible future therapies that target RNA-mediated pathways, but these ideas are still at an early research stage. Keep reading the full article or subsequent clinical studies to see whether specific circRNA markers or interventions progress to clinical validation.
Keep In Mind
This is an abstract/summary of a review article (RNA Biology). The content reflects preclinical and early translational literature; it does not report clinical validation of circRNA biomarkers or approved therapies. Interpret findings as exploratory until validated in clinical studies.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationRNA biology
AuthorsMengmeng Jie, Qiushi Liao, Cheng Liu
Study typeJournal article, review
Indexed viaPubMed
Source typeResearch paper
PublishedJun 15, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Machine Learning Model Identifies Gut Biomarkers That May Help Diagnose IBD Patients
This study suggests machine learning of stool microbiome data could eventually help distinguish IBD (especially Crohn’s) from healthy people and some other bowel or systemic conditions.
Human gut flagellome profiling using FlaPro reveals TLR5-related phenotype-specific alterations in IBD.
This paper links specific features of the gut bacterial flagellome to TLR5-driven immune activation and reports a disease-associated shift in flagellin profiles in Crohn’s disease and ulcerative colitis, suggesting...
Understanding role of microbiota in Crohn's disease, ulcerative colitis
The article explains how gut bacteria may contribute to IBD and summarizes common tests and treatments people are likely to encounter. It highlights emerging microbial therapies (probiotics and FMT) that some patients...